Genentech

Genentech to eliminate 474 positions
Genentech to eliminate 474 positions
Beckers Hospital Review
Genentech
layoffs
COVID-19
Flag link:
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
BioSpace
Genentech
Roche
clinical trials
Tecentriq
ovarian cancer
Flag link:
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
Flag link:
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
Flag link:
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Denali Therapeutics
Genentech
DNL747
Flag link:
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
BioSpace
Genentech
clinical trials
wet age-related macular degeneration
ranibizumab
Flag link:
Genentech posts long-term data on near-approval Soliris rival
Genentech posts long-term data on near-approval Soliris rival
Fierce Biotech
Genentech
satralizumab
Soliris
Alexion
NMOSD
Flag link:
3 Roche Companies Hope to Make Clinical Trials More Efficient
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
Flag link:
FDA approves Genentech’s Tecentriq as first-line monotherapy for certain people with metastatic NSCLC
FDA approves Genentech’s Tecentriq as first-line monotherapy for certain people with metastatic NSCLC
Pharmaceutical Business Review
Genentech
Roche
Tecentriq
FDA
metastatic non-small cell lung cancer
Flag link:
Genentech lures Regev from Broad Institute to lead research and early development
Genentech lures Regev from Broad Institute to lead research and early development
Fierce Biotech
Genentech
Broad Institute
R&D
Aviv Regev
Flag link:
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Fierce Pharma
Roche
Genentech
Novo Nordisk
AbbVie
Fortune
employees
Flag link:
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Experts float Roche stroke drug Activase as potential COVID-19 therapy
Fierce Pharma
Roche
Genentech
Activase
stroke
COVID-19
Flag link:
Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia
Roche Tests Arthritis Drug Actemra for COVID-19 Pneumonia
Motley Fool
Roche
Genentech
Actemra
FDA
clinical trials
COVID-19
Flag link:
Genentech's Esbriet Granted Breakthrough Therapy Designation for uILD
Genentech's Esbriet Granted Breakthrough Therapy Designation for uILD
BioSpace
Genentech
Esbriet
uILD
breakthrough therapy
FDA
Flag link:
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Genentech pays Bicycle $30M upfront to form discovery-stage immuno-oncology pact
Fierce Biotech
Roche
Genentech
Bicycle Therapeutics
R&D
immuno-oncology
Flag link:
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
If biotech had a Mount Rushmore, whose heads would you chisel in the granite?
Stat
biotech
Jeff Leiden
Vertex Pharmaceuticals
Herb Boyer
Bob Swanson
Genentech
Amgen
George Rathmann
Gordon Binder
Flag link:
Roche's Tecentriq fails trial in form of urothelial cancer
Roche's Tecentriq fails trial in form of urothelial cancer
Reuters
Roche
Genentech
clinical trials
Tecentriq
urothelial cancer
bladder cancer
Flag link:
Who are the 10 Most Innovative Biopharma Companies?
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
innovation
Regeneron
Verily
Illumina
Biogen
Bayer
Bluebird Bio
Novartis
GSK
Genentech
Amgen
Flag link:
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
Arcus and Roche Partner on Colorectal and Pancreatic Cancer Trials
BioSpace
Roche
Genentech
Arcus Biosciences
clinical trials
colorectal cancer
pancreatic cancer
AB928
Flag link:
Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says
Roche's flu med Xofluza drives drug resistance and may be a bad choice for kids, study says
Fierce Pharma
Roche
Genentech
Xofluza
pediatrics
Flag link:

Pages